ImmunoGen Message Board - Msg: 33091141

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gary Mohilner who wrote (5640)	12/14/2020 12:38:37 PM
From: Area51	of 5665

IMGN getting some impressive action today. I think you have to like it if it can stay over $7? 12/4/2020: Cowen analyst John Scott reiterated an Outperform rating and on Immunogen Inc. (NASDAQ: IMGN) and highlighted the company as his Best Biotech Idea for 2021. What the street appears to be missing is the de-risked first-in-class potential of lead drugmirvetuximab. https://www.streetinsider.com/Analyst+Comments/Immunogen+Inc.+(IMGN)+Names+Top+Biotech+Idea+for+2021+at+Cowen/17682898.html

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next